October 14, 2013 | Evry, France | Transversale Santé Symposium on Personalized Medicine & Biomarkers

 

 

Jean-Gabriel Judde (XenTech’s CSO & Founder) will present how the use of large patient-derived tumor xenograft (PDX) panels fosters the discovery of cancer biomarkers for patients’ stratification & personalized medicine.

 

Location: Genopole, Evry, France